MK
Manoj Kumar
About Manoj Kumar
Data last updated:
Manoj Kumar has 9 years in corporate governance. Holds Director role. Currently with 2 companies, including Vetgrow Pharma Private Limited and Vetcraze Pharma Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Vetgrow Pharma Private Limited at ₹3.04 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Vetgrow Pharma Private Limited U74999MP2017PTC043810 | Director | 25 Jul 2017 | 2017 | ₹3.04 Cr (FY 2024) | Active |
| Vetcraze Pharma Private Limited U46497MP2026PTC086460 | Director | 23 Aug 2026 | 2026 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Manoj Kumar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Manoj Kumar
Manoj Kumar has 9 years in corporate governance. Holds Director role. Currently with 2 companies, including Vetgrow Pharma Private Limited and Vetcraze Pharma Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Vetgrow Pharma Private Limited at ₹3.04 Cr (FY 2024).
Manoj Kumar is associated with 2 companies as Director, including Vetgrow Pharma Private Limited (₹3.04 Cr), Vetcraze Pharma Private Limited.
Manoj Kumar has expertise in General Business.
Manoj Kumar has 9 years in corporate governance.
By reported revenue, the largest current company of Manoj Kumar is Vetgrow Pharma Private Limited, with revenue of ₹3.04 Cr (FY 2024).
Manoj Kumar currently holds positions at 2 companies: Vetgrow Pharma Private Limited (₹3.04 Cr), Vetcraze Pharma Private Limited.